MétaCan
Menu
← Back to cohort
Record W2614653076 · doi:10.1161/str.47.suppl_1.tp428

Abstract TP428: Antithrombotic Therapy in Patients With Atrial Fibrillation and Prior Stroke in GLORIA- AF Phase II (Global Registry on Long-term Oral Antithrombotic Treatment in Patients With Atrial Fibrillation, Phase II)

2016· article· en· W2614653076 on OpenAlexaff
Hans‐Christoph Diener, Menno V. Huisman, Jonathan L. Halperin, Sérgio Dubner, Shang‐Hung Chang, Kenneth J. Rothman, Kristina Zint, Amelie Elsaesser, Miney Paquette, Christine Teutsch, G Y H Lip, Dorothee B. Bartels

Bibliographic record

VenueStroke · 2016
Typearticle
Languageen
FieldMedicine
TopicAtrial Fibrillation Management and Outcomes
Canadian institutionsBoehringer Ingelheim (Canada)
Fundersnot available
KeywordsMedicineAtrial fibrillationStroke (engine)AntithromboticVitamin K antagonistInternal medicineCohortFibrinolytic agentCardiologyWarfarin

Abstract

fetched live from OpenAlex

Introduction: Given their substantial risk of recurrent stroke, patients with atrial fibrillation (AF) and prior stroke are at highest risk. Such patients should be pre-scribed oral anticoagulants (OAC), either a Vitamin K Antagonist (VKA) or Non-VKA OAC (NOAC). Methods: Using an inception cohort design, GLORIA-AF collected data on choice of antithrombotic therapy for patients with newly identified AF at risk of stroke (CHA2DS2VASc scores ≥ 1) in the course of routine care. We examined the use of an-tithrombotic therapy in those with prior stroke. Results: From 15,092 patients in Phase II of GLORIA-AF enrolled in 5 geographical regions worldwide (Europe, North America, Asia, Latin America and Africa/Middle East), 1,582 patients (median age 75 years, 54.9% male) had previous stroke, with a median CHA2DS2-VASc score of 5, compared with a score of 3 in those without previ-ous stroke (n=13,500). For 10 patients previos stroke status was unknown. In those with previous stroke, VKA alone was prescribed in 25.2%, VKA plus an-tiplatelet therapy (AP) in 5.8%, NOAC alone in 42.9%, NOAC plus AP in 7.7%, and AP alone in 12.1%; 6.3% received no antithrombotic therapy. Proportions were broadly similar in males and females. In comparison, among patients without prior stroke the proportions on AP only or no therapy were a little higher (20.2 versus 18.3%). Among those with prior stroke, proportions on AP alone in Asia, Europe, and North America were 24.2, 9.9 and 5.6% respectively, while proportions on no antithrombotic therapy in these regions were 16.3, 3.2 and 4.5%. Conclusion: In this prospective registry, AF patients with prior stroke and a median CHA2DS2-VASc score of 5, approximately 18% were treated with AP alone or no an-tithrombotic therapy, and the treatment gap was greater in Asia than in Europe or North America.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.004
Threshold uncertainty score0.007

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.002
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0010.002
Science and technology studies0.0000.000
Scholarly communication0.0010.001
Open science0.0010.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0020.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.028
GPT teacher head0.321
Teacher spread0.292 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2016
Admission routes1
Has abstractyes

Explore more

Same venueStroke→Same topicAtrial Fibrillation Management and Outcomes→French-language works237,207→